比较简易肌少症风险评估与SARC-F在社区老年人肌少症筛查中的价值
该诊断准确性研究纳入384名成都社区老年人,以亚洲肌少症工作组(AWGS)标准为金标准,比较MSRA-7、MSRA-5与SARC-F筛查肌少症的诊断价值。
要点
- MSRA-5敏感性90.2%、特异性70.6%,SARC-F敏感性29.5%、特异性98.1%。
- MSRA-7诊断准确性低于SARC-F和MSRA-5(AUC 0.70)。
核心结论
- MSRA-5可作为中国社区老年人肌少症的新型筛查工具,SARC-F也适用,两者诊断准确性相似。
研究设计与样本
- 诊断准确性研究,在成都社区招募384名老年人,以AWGS标准为金标准比较三种量表的诊断价值。
主要发现
- SARC-F敏感性29.5%、特异性98.1%,MSRA-7敏感性86.9%、特异性39.6%,MSRA-5敏感性90.2%、特异性70.6%。
- SARC-F、MSRA-7、MSRA-5的AUC分别为0.89(95%CI 0.86-0.92)、0.70(95%CI 0.65-0.74)、0.85(95%CI 0.81-0.89)。
- SARC-F与MSRA-7之间及MSRA-7与MSRA-5之间的AUC差异有统计学意义(P<.001),SARC-F与MSRA-5之间差异无统计学意义(P=.130)。
关键数值与推荐
- 以AWGS肌少症标准为金标准,采用生物电阻抗分析(BIA)测肌肉量、握力测肌力、步速测躯体功能。
临床怎么用
- 社区老年人肌少症筛查可选用MSRA-5(敏感性较高)或SARC-F(特异性较高),两者诊断准确性相当。
局限性
- MSRA的诊断价值需在不同人群中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Mini Sarcopenia Risk Assessment (MSRA), a new sarcopenia screening tool, has 2 versions: MSRA-7 (full version, 7 items) and MSRA-5 (short version, 5 items). We aimed to compare the diagnostic values of MSRA-7 and MSRA-5 to SARC-F for screening sarcopenia. DESIGN: A diagnostic accuracy study. SETTING: A community in Chengdu, China. PARTICIPANTS: Older adults. MEASUREMENTS: Muscle mass, strength, and physical performance were tested using a bioimpedance analysis (BIA) device, handgrip strength, and walking speed, respectively. Using the Asian Working Group for Sarcopenia (AWGS) criteria as the gold standard, the sensitivity/specificity analyses of the 3 scales were assessed. Receiver operating characteristic (ROC) curves and area under the ROC curves (AUC) were used to compare the overall diagnostic accuracy of the 3 scales. RESULTS: We recruited 384 participants. Against the AWGS criteria, SARC-F had a sensitivity of 29.5% and a specificity of 98.1%, and the MSRA-7 had a sensitivity of 86.9% and a specificity of 39.6%, whereas the MSRA-5 had a sensitivity of 90.2% and a specificity of 70.6%. The AUCs of SARC-F, MSRA-7, and MSRA-5 were 0.89 [95% confidence interval (CI), 0.86-0.92], 0.70 (95% CI, 0.65-0.74), and 0.85 (95% CI, 0.81-0.89), respectively. The differences in AUCs between SARC-F and MSRA-7 and in those between MSRA-7 and MSRA-5 were statistically significant (P <.001), but the difference between SARC-F and MSRA-5 was not statistically significant (P = .130). CONCLUSION: MSRA-5 may serve as a novel screening tool for sarcopenia in Chinese community-dwelling older adults. SARC-F, a class screening tool, is also suitable for this population. MSRA-5 and SARC-F demonstrated a similar diagnostic accuracy in our study population. MSRA-5 has better sensitivity, whereas SARC-F has better specificity. However, the diagnostic value of MSRA needs to be further validated in different populations.
引用
- Yang M, Hu X, Xie L, et al. Comparing Mini Sarcopenia Risk Assessment With SARC-F for Screening Sarcopenia in Community-Dwelling Older Adults. J Am Med Dir Assoc. 2018. PMID: 29909052. doi:10.1016/j.jamda.2018.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。